AJANTPHARM2024-04-202024-07-18Resolution1 AJANTPHARM2024-07-18 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution1in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution1in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution1 AJANTPHARM2024-04-202024-07-18Resolution2 AJANTPHARM2024-07-18 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution2in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution2 AJANTPHARM2024-04-202024-07-18Resolution3 AJANTPHARM2024-07-18 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution3in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution3 AJANTPHARM2024-04-202024-07-18Resolution4 AJANTPHARM2024-07-18 Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution4in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution4in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution4 AJANTPHARM2024-04-202024-07-18Resolution5 AJANTPHARM2024-07-18 Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution5in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution5in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution5 AJANTPHARM2024-04-202024-07-18Resolution6 AJANTPHARM2024-07-18 Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution6in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution6in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution6in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution6 AJANTPHARM2024-04-202024-07-18Resolution7 AJANTPHARM2024-07-18 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution7in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution7in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution7 AJANTPHARM2024-04-202024-07-18Resolution8 AJANTPHARM2024-07-18 Resolution8in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PromoterAndPromoterGroupMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PublicInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PublicInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PublicInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18Resolution8in-bse-voting:PublicInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PublicNonInstitutionMemberin-bse-voting:EVotingMember AJANTPHARM2024-07-18Resolution8in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PollMember AJANTPHARM2024-07-18Resolution8in-bse-voting:PublicNonInstitutionMemberin-bse-voting:PostalBallotMember AJANTPHARM2024-07-18 Resolution8in-bse-voting:PublicNonInstitutionMemberin-bse-voting:TotalVotingMember AJANTPHARM2024-07-18Resolution8in-bse-voting:TotalShareholdingMember AJANTPHARM2024-07-18 Resolution8 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AJANTPHARM INE031B01049 Ajanta Pharma Limited AGM 2024-07-18 71296 0 0 4 58 8 Ordinary false 1 - To receive, consider and adopt:na) the Audited Standalone Financial Statements of the Company for the Financial Year ended March 2024 together with the Reports of the Board of Directors and the Auditors thereon; andnb) the Audited Consolidated Financial Statements of the Company for the Financial year ended 31 March 2024 together with the Report of the Auditors thereon. 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27223649 84.74 27223649 0 100 0 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27223649 84.74 27223649 0 100 0 9997802 313735 3.14 313663 72 99.98 0.02 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313663 72 99.98 0.02 124887774 110301161 88.32 110301089 72 100 0 Ordinary false 2 - RESOLVED THAT the first interim dividend of ? 25 per equity share and second interim dividend of ? 26 per equity share approved by the Board of Directors of the Company and already paid, be and are hereby confirmed/ratified 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27264424 84.87 27264424 0 100 0 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27264424 84.87 27264424 0 100 0 9997802 313735 3.14 313663 72 99.98 0.02 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313663 72 99.98 0.02 124887774 110341936 88.35 110341864 72 100 0 Ordinary false 3 - To appoint a Director in place of Mr. Mannalal B. Agrawal (DIN: 00073828), who retires by rotation and being eligible, offers himself for re-appointment 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 21183771 6069378 77.73 22.27 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 21183771 6069378 77.73 22.27 9997802 313735 3.14 313412 323 99.9 0.1 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313412 323 99.9 0.1 124887774 110330661 88.34 104260960 6069701 94.5 5.5 Special false 4 - RESOLVED THAT pursuant to the provisions of Section 149, 152 read with Schedule IV of the Companies Act 2013 (the Act), Regulation 17 (1C) of SEBI (LODR) Regulations, 2015, Mr. DavidnRasquinha (DIN: 01172654) be and is hereby appointed as an Independent Director of the Company for a term of 5 (five) years from 2nd May, 2024, not liable to retire by rotation 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 9997802 313735 3.14 313402 333 99.89 0.11 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313402 333 99.89 0.11 124887774 110330661 88.34 110282912 47749 99.96 0.04 Special false 5 - RESOLVED THAT pursuant to the provisions of Section 149, 152 read with Schedule IV of the Companies Act 2013 (the Act), Regulation 17 (1C) of SEBI (LODR) Regulations, 2015, Ms. Medha Joshi (DIN: 00328174) be and is hereby appointed as an Independent Director of the Company for a term of 5 (five) years from 2nd May, 2024, not liable to retire by rotation 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 9997802 313735 3.14 313412 323 99.9 0.1 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313412 323 99.9 0.1 124887774 110330661 88.34 110282922 47739 99.96 0.04 Special false 6 - RESOLVED THAT pursuant to the provisions of Section 149, 152 read with Schedule IV of the Companies Act 2013 (the Act), Regulation 17 (1C) of SEBI (LODR) Regulations, 2015, Mr. RajeshnDalal (DIN: 03504969) be and is hereby appointed as an Independent Director of the Company for a term of 5 (five) years from 2nd May, 2024, not liable to retire by rotation 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 27204087 49062 99.82 0.18 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 27204087 49062 99.82 0.18 9997802 313735 3.14 313402 333 99.89 0.11 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313402 333 99.89 0.11 124887774 110330661 88.34 110281266 49395 99.96 0.04 Special false 7 - RESOLVED THAT pursuant to the provisions of Section 149, 152 read with Schedule IV of the Companies Act 2013 (the Act), Regulation 17 (1C) of SEBI (LODR) Regulations, 2015, Ms. Simi Thapar (DIN: 10470498) be and is hereby appointed as an Independent Director of the Company for a term of 5 (five) years from 2nd May, 2024, not liable to retire by rotation 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 27205733 47416 99.83 0.17 9997802 313735 3.14 313366 369 99.88 0.12 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313366 369 99.88 0.12 124887774 110330661 88.34 110282876 47785 99.96 0.04 Ordinary false 8 - RESOLVED THAT pursuant to the provisions of Section 148 and other applicable provisions, remuneration of ? 6.50 lakhs plus GST and reimbursement of actual travel and out of pocket expenses, fixed by the Board for M/s. RA & Co., Cost Accountants, (Firm Registration No. 000242), Cost Auditors to conduct the audit of the cost records for the financial year ending 31 March 2025, be and is hereby ratified 82763777 82763777 100 82763777 0 100 0 82763777 0 0 0 0 0 0 82763777 0 0 0 0 0 0 82763777 82763777 100 82763777 0 100 0 32126195 27253149 84.83 27253149 0 100 0 32126195 0 0 0 0 0 0 32126195 0 0 0 0 0 0 32126195 27253149 84.83 27253149 0 100 0 9997802 313735 3.14 313412 323 99.9 0.1 9997802 0 0 0 0 0 0 9997802 0 0 0 0 0 0 9997802 313735 3.14 313412 323 99.9 0.1 124887774 110330661 88.34 110330338 323 100 0